Skip to Content Skip to Search Skip to Navigation Skip to Sub Navigation

Faculty Information

Xin Li, PHD

Xin Li, PhD

Associate Professor
Basic Science and Craniofacial Biology
Room 901D Dental Center, 421 First Avenue
Phone: 212-992-7009
Fax: 212-995-4087
E-mail: xl15@nyu.edu

Education

PhD, Physiology, Rutgers University
MS, Physiology, Chinese Academy of Sciences, Beijing, China
BS, Biology, Shandong University

Honors/Credentials

  • 2009 American Society of Bone and Mineral Research (ASBMR) Young Investigator Award
  • 2009 ASBMR-Harold M. Frost Young Investigator Award
  • 2009 IX International Cancer and Bone Meeting Young Investigator Award
  • 2011 Outstanding Trainee Presentation, 4th New York Skeletal Biology and Medicine
  • 2015 Young Investigator Award, Society for Basic Urologic Research
  • 2017 Outstanding Teacher Award, NYU Dentistry Faculty Council

Research Interests / Professional Overview

We are intrigued to investigate the impact of metabolites that function as non-autonomous signals in pathophysiological conditions such as aging and diabetes. Recently, we found that succinate, a TCA cycle metabolite was significantly elevated in mammalian and bacteria exposed to high glucose. Our recent paper in Nature Communications demonstrates that succinate enhances osteoclastogenesis through its receptor Sucnr1 in vitro and in vivo. We will reveal a novel mechanism of succinate and its G-protein coupled receptor (SUCNR1) in osteoclastogenesis, inflammaging and aging-related bone loss.

We have postodotoral positions open, please see below for details:

We are seeking a well-trained researcher with excellent work ethic and the ability to join a NIH-funded group and work on projects to discover the mechanisms that regulate the interaction between microbiome and immune cells under normal and diseased conditions. The primary project is based on our recent finding on succinate stimulated osteoclastogenesis under diabetic condition in Nature Communications (https://www.nature.com/articles/ncomms15621). The applicant is expected to work independently as well as in collaboration with other group members to complete projects in a timely manner.

The candidate should have a PhD in Cell Biology, Biomedical Sciences, or related field. Hands-on experience in molecular biology and cell culture (primary cell culture and differentiation) are required. Familiarity with flow cytometry and FACS cell sorter is highly desirable. Priority will be given to candidates with strong oral communications and writing skills, as evidenced by a strong publication record. In addition to manuscripts, the candidate will be expected to participate in writing animal protocols and research proposals. Competitive salary and benefits commensurate with the candidate's qualifications.

Interested applicants should submit a brief statement of research interests, a CV, and three references to Dr. Xin Li at xl15@nyu.edu. The position is available immediately (Nov. 2017 until filled).

Preferred specific skills:

  • RNA-seq
  • PCR/qPCR
  • Cell culture
  • Western blot
  • Immunocytochemistry/Immunohistochemistry
  • Surgery in small animals
  • Flow cytometry
  • Bone marrow transplant
  • Genetic modification (transfection/transduction)

Current Funding

  • National Institute of Dental and Craniofacial Research (NIDCR)
  • National Cancer Institute (NCI) at National Institutes of Health (NIH)
  • New York University - University Research Challenge Fund (URCF)

Lab Members:

  • Assistant Research Scientist: Jian Yang PhD. Email: jy1651@nyu.edu
  • Associate Research Scientist: Yuqi Guo, MD, MS. Email: yg701@nyu.edu
  • Current NYU Master students: Ruohan Zhang
  • Current DDS student in honors research program: Wonkyu Seo
  • Visiting Scholars: Yaoyu Wang, DDS

Representative Publications

Complete listing available on the NYU Health Sciences Library site.

Search PubMed for articles.

My bibliography

http://www.ncbi.nlm.nih.gov/sites/myncbi/1rw8W6zateckx/bibliography/40603874/public/?sort=date&direction=descending

Guo Y, Xie C, Li X, Yang J, Yu T, Zhang R, Zhang T, Saxena D, Snyder M, Wu Y, et al. Succinate and its G-protein-coupled receptor stimulates osteoclastogenesis. Nat Commun. 2017 May 31;8:15621. doi: 10.1038/ncomms15621. PubMed PMID: 28561074; PubMed Central PMCID: PMC5460032.

Yang J, Lu C, Wei J, Guo Y, Liu W, Luo L, Fisch G, Li X. Inhibition of KPNA4 attenuates prostate cancer metastasis. Oncogene. 2017 May 18;36(20):2868-2878. doi: 10.1038/onc.2016.440. Epub 2016 Dec 12. PubMed PMID: 27941876; PubMed Central PMCID: PMC5436935.

Yu T, Wang C, Yang J, Guo Y, Wu Y, Li X. Metformin inhibits SUV39H1-mediated migration of prostate cancer cells. Oncogenesis. 2017 May 1;6(5):e324. doi: 10.1038/oncsis.2017.28. PubMed PMID: 28459432; PubMed Central PMCID: PMC5523061.

Guo Y, Yu T, Yang J, Zhang T, Zhou Y, He F, Kurago Z, Myssiorek D, Wu Y, Lee P, Li X. Metformin inhibits salivary adenocarcinoma growth through cell cycle arrest and apoptosis. Am J Cancer Res. 2015 Nov 15;5(12):3600-11. eCollection 2015.

Li X, Guo Y, Yan W, Snyder MP, Li X. Metformin Improves Diabetic Bone Health by Re-Balancing Catabolism and Nitrogen Disposal. PLoS One. 2015 Dec 30;10(12):e0146152. doi: 10.1371/journal.pone.0146152. eCollection 2015.

Yang J, Wei J, Wu Y, Wang Z, Guo Y, Lee P, Li X. Metformin induces ER stress-dependent apoptosis through miR-708-5p/NNAT pathway in prostate cancer. Oncogenesis. 2015 Jun 15;4:e158. doi: 10.1038/oncsis.2015.18. PubMed PMID: 26075749; PubMed Central PMCID: PMC4491613.

Wei J, Wang Z, Makarov D, Li X. Current treatments and novel therapeutic targets for castration resistant prostate cancer with bone metastasis. Am J Clin Exp Urol 2013 Dec 25;1(1):30-8. eCollection 2013. Review. PubMed PMID: 25374898; PubMed Central PMCID: PMC4219282.

Akinyeke, Tunde; Matsumura, Satoko; Wang, Xinying; Wu, Yingjie; Schalfer, Eric D; Saxena, Anjana; Yan, Wenbo; Logan, Susan K; Li, Xin. Metformin Targets c-MYC Oncogene to Prevent Prostate Cancer. Carcinogenesis. 2013 Dec;34(12):2823-32. doi: 10.1093/carcin/bgt307. Epub 2013 Oct 15. PubMed PMID: 24130167; PubMed Central PMCID: PMC3845895.

Yan W, Li X. Impact of diabetes and its treatments on skeletal diseases. Front Med. 2013 Mar;7(1):81-90. doi: 10.1007/s11684-013-0243-9. Epub 2013 Feb 2. Review. PubMed PMID: 23377889.

Soki FN*, Li X*, Berry J, Koh A, Sinder BP, Qian X, Kozloff KM, Taichman RS, McCauley LK. The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches, Journal of Cellular Biochemistry, 2012 [Epub ahead of print]. * equal contribution

Pushalkar S, Ji X, Li Y, Estilo C, Yegnanarayana R, Singh B, Li X and Saxena D. Comparison of oral microbiota in tumor and non-tumor tissues of patients with Oral Squamous Cell Carcinoma. BMC Microbiology. 2012 Jul 20;12(1):144.

Park SI, Liao J, Berry JE, Li X, Koh AJ, Michalski MN, Eber MR, Soki FN, Sadler WD, Sud S, Tisdelle SM, Daignault SD, Nemeth JA, Snyder LA, Wronski TJ, Pienta KJ, McCauley LK. Cyclophosphamide Creates a Receptive Microenvironment for Prostate Cancer Skeletal Metastasis. Cancer Research 2012, May 15;72(10):2522-32.

Li X, Liao JH, Koh AJ, Sadler WD, Rosol TJ, Pienta KJ and McCauley LK. Drugs Which Inhibit Osteoclast Function Suppress Tumor Growth through Calcium Decrease in Bone. Bone 2011, 48(6):1354-61 PMID:21419883.

Li X, Koh AJ, Wang Z, Soki FN, Park S, Pienta KJ and McCauley LK. Inhibitory Effects of Megakaryocytic cells in Prostate Cancer Skeletal Metastasis. J Bone Miner Res. 2011 Jan;26(1):125-34.

Li X*, Loberg R*, Liao J, Ying C, Snyder LA, Pienta KJ and McCauley LK. A Destructive Cascade Mediated by CCL2 Facilitates Prostate Cancer Growth in Bone. Cancer Research. 2009 Feb 15;69(4):1685-92 (Highlighted Feature).

Li X, McCauley LK. Osteonecrosis of the jaw: Meeting Report from Skeletal Complications of Malignancy V. IBMS BoneKEy. 2008 Aug;5(8):289-293.

Liao J, Li X, Koh AJ, Berry JE, Thudi N, Rosol TJ, Peinta KJ and McCauley LK. Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions. International Journal of Cancer 2008; Aug 26;123(10):2267-2278.

McCauley LK and Li X. Distinguishing features of the oral cavity and its predisposition to osteonecrosis. J Musculoskelet Neuronal Interact 2007; 7(4): 356-357.